NCT04682756

Brief Summary

Early diagnosis of NSTEMI and UA patients is mainly through the construction of machine learning model.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

December 20, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 24, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

December 31, 2020

Status Verified

December 1, 2020

Enrollment Period

1 year

First QC Date

December 19, 2020

Last Update Submit

December 29, 2020

Conditions

Keywords

NSTEMIUAMachine Learning

Outcome Measures

Primary Outcomes (1)

  • Accurate diagnosis of NSTEMI from patients with acute chest pain

    NSTEMI patients are accurately diagnosed from patients with acute chest pain through a trained machine learning algorithm. Our model uses multi-fold cross-validation and ROC-AUC curve as the measurement index, 75% of the data are modeled, and 25% of the data verify the effect of the model. For this reason, we will calculate the accuracy, specificity and likelihood ratio when the sensitivity cutoff value is 0.9.

    Within 1 year

Study Arms (2)

CNN model

Electronic health information of NSTEMI and UA patients in two chest pain centers from 2017 to 2019 was collected,After manual labeling, the characteristics of patient admission records were selected, and through the construction of one-dimensional convolution (CNN) model. Taking the multi-fold cross-validation and ROC-AUC curve as the measurement index, 75% of the data are modeled and 25% of the data are used to verify the effect of the model.

Diagnostic Test: The model of machine learning

XG boost

Through the construction of XG boost model,taking the multi-fold cross-validation and ROC-AUC curve as the measurement index, 75% of the data are modeled and 25% of the data are used to verify the effect of the model.

Diagnostic Test: The model of machine learning

Interventions

Early diagnosis of NTEMI patients by machine learning model

CNN modelXG boost

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with NSTEMI and UA were included in the Chest Pain Center of the First Affiliated Hospital of Xinjiang Medical University and the First Affiliated Hospital of Medical College of Shihezi University from 2017 to 2019.

You may qualify if:

  • Patients were included and excluded strictly according to the diagnostic criteria of Chinese guidelines for diagnosis and treatment of Non-STsegment elevation acute coronary syndrome (2016). The patients were admitted to the hospital with chest pain as the main complaint, and were admitted to the first affiliated Hospital of Xinjiang Medical University and the first affiliated Hospital of Medical College of Shihezi Univ- ersity. the patients were diagnosed as NSTEMI and UA by coronary angiography (age range from 30 to 75 years old).

You may not qualify if:

  • \- 1. Patients with STEMI, aortic dissecting aneurysm, pneumothorax and other non-cardiogenic chest pain. 2.Severe hepatorenal failure, primary tumor without surgical treatment, non-severe infection complicated with shock and pregnant women. 3.Previous severe valvular disease, viral myocarditis, pericardial effusion, cardiac pacemaker implantation, cardiogenic shock with serious complications, hypertensive heart disease, various cardiomyopathy, congenital heart disease, etc.
  • Patients with heart disease, AECOPD, lung tumor and hyperthyroidism were diagnosed in the past.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The first affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, 830000, China

Location

Related Publications (15)

  • Cuocolo R, Perillo T, De Rosa E, Ugga L, Petretta M. Current applications of big data and machine learning in cardiology. J Geriatr Cardiol. 2019 Aug;16(8):601-607. doi: 10.11909/j.issn.1671-5411.2019.08.002.

    PMID: 31555327BACKGROUND
  • Ambale-Venkatesh B, Yang X, Wu CO, Liu K, Hundley WG, McClelland R, Gomes AS, Folsom AR, Shea S, Guallar E, Bluemke DA, Lima JAC. Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis. Circ Res. 2017 Oct 13;121(9):1092-1101. doi: 10.1161/CIRCRESAHA.117.311312. Epub 2017 Aug 9.

    PMID: 28794054BACKGROUND
  • Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS One. 2017 Apr 4;12(4):e0174944. doi: 10.1371/journal.pone.0174944. eCollection 2017.

    PMID: 28376093BACKGROUND
  • Patel BB, Sperotto F, Molina M, Kimura S, Delgado MI, Santillana M, Kheir JN. Avoidable Serum Potassium Testing in the Cardiac ICU: Development and Testing of a Machine-Learning Model. Pediatr Crit Care Med. 2021 Apr 1;22(4):392-400. doi: 10.1097/PCC.0000000000002626.

    PMID: 33332868BACKGROUND
  • Groepenhoff F, Eikendal ALM, Bots SH, van Ommen AM, Overmars LM, Kapteijn D, Pasterkamp G, Reiber JHC, Hautemann D, Menken R, Wittekoek ME, Hofstra L, Onland-Moret NC, Haitjema S, Hoefer I, Leiner T, den Ruijter HM. Cardiovascular imaging of women and men visiting the outpatient clinic with chest pain or discomfort: design and rationale of the ARGUS Study. BMJ Open. 2020 Dec 15;10(12):e040712. doi: 10.1136/bmjopen-2020-040712.

    PMID: 33323438BACKGROUND
  • Kwon JM, Jeon KH, Kim HM, Kim MJ, Lim S, Kim KH, Song PS, Park J, Choi RK, Oh BH. Deep-learning-based risk stratification for mortality of patients with acute myocardial infarction. PLoS One. 2019 Oct 31;14(10):e0224502. doi: 10.1371/journal.pone.0224502. eCollection 2019.

    PMID: 31671144BACKGROUND
  • Chowdhury MEH, Alzoubi K, Khandakar A, Khallifa R, Abouhasera R, Koubaa S, Ahmed R, Hasan MA. Wearable Real-Time Heart Attack Detection and Warning System to Reduce Road Accidents. Sensors (Basel). 2019 Jun 20;19(12):2780. doi: 10.3390/s19122780.

    PMID: 31226858BACKGROUND
  • Wu CC, Hsu WD, Islam MM, Poly TN, Yang HC, Nguyen PA, Wang YC, Li YJ. An artificial intelligence approach to early predict non-ST-elevation myocardial infarction patients with chest pain. Comput Methods Programs Biomed. 2019 May;173:109-117. doi: 10.1016/j.cmpb.2019.01.013. Epub 2019 Jan 31.

    PMID: 31046985BACKGROUND
  • Bernatz S, Ackermann J, Mandel P, Kaltenbach B, Zhdanovich Y, Harter PN, Doring C, Hammerstingl R, Bodelle B, Smith K, Bucher A, Albrecht M, Rosbach N, Basten L, Yel I, Wenzel M, Bankov K, Koch I, Chun FK, Kollermann J, Wild PJ, Vogl TJ. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features. Eur Radiol. 2020 Dec;30(12):6757-6769. doi: 10.1007/s00330-020-07064-5. Epub 2020 Jul 16.

    PMID: 32676784BACKGROUND
  • Md Idris N, Chiam YK, Varathan KD, Wan Ahmad WA, Chee KH, Liew YM. Feature selection and risk prediction for patients with coronary artery disease using data mining. Med Biol Eng Comput. 2020 Dec;58(12):3123-3140. doi: 10.1007/s11517-020-02268-9. Epub 2020 Nov 6.

    PMID: 33155096BACKGROUND
  • Allen B, Molokie R, Royston TJ. Early Detection of Acute Chest Syndrome Through Electronic Recording and Analysis of Auscultatory Percussion. IEEE J Transl Eng Health Med. 2020 Sep 30;8:4900108. doi: 10.1109/JTEHM.2020.3027802. eCollection 2020.

    PMID: 33094035BACKGROUND
  • Eberhard M, Nadarevic T, Cousin A, von Spiczak J, Hinzpeter R, Euler A, Morsbach F, Manka R, Keller DI, Alkadhi H. Machine learning-based CT fractional flow reserve assessment in acute chest pain: first experience. Cardiovasc Diagn Ther. 2020 Aug;10(4):820-830. doi: 10.21037/cdt-20-381.

    PMID: 32968637BACKGROUND
  • Ma Q, Ma Y, Yu T, Sun Z, Hou Y. Radiomics of Non-Contrast-Enhanced T1 Mapping: Diagnostic and Predictive Performance for Myocardial Injury in Acute ST-Segment-Elevation Myocardial Infarction. Korean J Radiol. 2021 Apr;22(4):535-546. doi: 10.3348/kjr.2019.0969. Epub 2020 Nov 30.

    PMID: 33289360BACKGROUND
  • Lee HC, Park JS, Choe JC, Ahn JH, Lee HW, Oh JH, Choi JH, Cha KS, Hong TJ, Jeong MH; Korea Acute Myocardial Infarction Registry (KAMIR) and Korea Working Group on Myocardial Infarction (KorMI) Investigators. Prediction of 1-Year Mortality from Acute Myocardial Infarction Using Machine Learning. Am J Cardiol. 2020 Oct 15;133:23-31. doi: 10.1016/j.amjcard.2020.07.048. Epub 2020 Jul 26.

    PMID: 32811651BACKGROUND
  • Zheng Y, Li T. Letter to the Editor concerning the article "Machine learning for prediction of 30-day mortality after ST elevation myocardial infarction". Int J Cardiol. 2018 Sep 1;266:41. doi: 10.1016/j.ijcard.2017.11.061. No abstract available.

    PMID: 29887469BACKGROUND

MeSH Terms

Conditions

Non-ST Elevated Myocardial InfarctionAngina, Unstable

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisAngina PectorisChest PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Aikeliyaer Ainiwaer, M.D

    First Affiliated Hospital of Xinjiang Medical University

    PRINCIPAL INVESTIGATOR
  • Quan Qi, Ph.D

    College of Information and Technology, Shihezi University

    STUDY DIRECTOR
  • Yi Ying Du, M.D

    First Affiliated Hospital of Xinjiang Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Cardiology

Study Record Dates

First Submitted

December 19, 2020

First Posted

December 24, 2020

Study Start

December 20, 2020

Primary Completion

December 20, 2021

Study Completion

June 1, 2022

Last Updated

December 31, 2020

Record last verified: 2020-12

Locations